| |
| |
|
| Insider
Information: |
Kaufmann Michael C |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
613,483 |
|
|
Indirect Shares
|
10 |
|
|
| Direct
Value |
$58,841,671 |
|
|
|
Indirect Value
|
$961 |
|
|
| Total
Shares |
613,493 |
|
|
| Total
Value |
$58,842,632 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
CEO, Director |
2022-08-15 |
601,065 |
2022-08-15 |
10 |
Premium* |
|
|
MSC Industrial Direct Co Inc |
MSM |
Director |
2024-01-26 |
12,418 |
2015-09-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2014-02-11 |
4 |
S |
$67.57 |
$21,317,997 |
D/D |
(315,495) |
115,969 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2014-02-11 |
4 |
OE |
$27.29 |
$9,275,469 |
D/D |
315,495 |
431,464 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2022-08-15 |
4 |
D |
$69.32 |
$11,660,594 |
D/D |
(168,214) |
601,065 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
132,857 |
672,988 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
98,866 |
536,433 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2022-08-15 |
4 |
OE |
$39.81 |
$3,833,345 |
D/D |
96,291 |
674,750 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO and CFO |
• • – |
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
95,238 |
430,196 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-02-07 |
4 |
S |
$41.71 |
$3,651,460 |
D/D |
(87,544) |
70,720 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2021-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
85,106 |
629,817 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-02-07 |
4 |
OE |
$22.90 |
$2,088,983 |
D/D |
80,648 |
158,264 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2021-08-15 |
4 |
D |
$51.70 |
$3,999,771 |
D/D |
(77,365) |
552,452 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2021-08-12 |
4 |
OE |
$41.60 |
$3,199,414 |
D/D |
76,909 |
613,342 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2020-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
74,516 |
480,995 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2014-02-10 |
4 |
S |
$67.00 |
$4,924,500 |
D/D |
(73,500) |
115,969 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2014-02-10 |
4 |
OE |
$27.29 |
$2,005,815 |
D/D |
73,500 |
189,469 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Executive Officer |
• • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
71,642 |
283,491 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2021-08-12 |
4 |
D |
$51.69 |
$3,547,536 |
D/D |
(68,631) |
544,711 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Executive Officer |
• • – |
2019-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
63,694 |
334,958 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2013-01-23 |
4 |
AS |
$44.95 |
$2,623,372 |
D/D |
(58,362) |
104,330 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2013-01-23 |
4 |
OE |
$27.29 |
$1,505,262 |
D/D |
55,158 |
162,692 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-27 |
4 |
OE |
$27.29 |
$1,450,682 |
D/D |
53,158 |
131,810 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2014-09-04 |
4 |
OE |
$41.10 |
$2,063,878 |
D/D |
50,216 |
168,792 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2014-09-04 |
4 |
AS |
$74.95 |
$3,763,689 |
D/D |
(50,216) |
118,576 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CFO |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
49,188 |
230,986 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-27 |
4 |
AS |
$44.95 |
$1,850,322 |
D/D |
(41,164) |
90,646 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
